New Regulation for Illinois Prescribers with Controlled Substance License
Tuesday, February 13, 2018
Posted by: Susan Swart
All Prescribers with an Illinois Controlled Substance License Must Enroll in the Illinois Prescription Monitoring Program (PMP)
Beginning January 1, 2018, Public Act 100-0564 requires all prescribers with an Illinois controlled substance license to enroll in the Illinois Prescription Monitoring Program (PMP) https://www.ilpmp.org/ through the Illinois Department of Human Services (IDHS).
Prescribers are additionally required to attempt to check the PMP prior to writing aninitial prescription of a Schedule II narcotics, such as opioids. That attempt must be documented in the patient’s medical record.
The PMP is an electronic tool that collects information on controlled substance prescriptions, schedules II, III, IV and V. This data is reported on a daily basis by retail pharmacies dispensing in Illinois. The Mission of the PMP is to enhance a prescriber’ and dispenser’s capacity to review a patient’s prescription history for therapeutic and clinical reasons and to assist in the effective treatment of patients seeking medical care. The PMP was authorized by the Illinois Controlled Substances Act (720 ILCS 570/316) and strictly adheres to HIPAA and all access, disclosure and confidentiality provisions of Illinois Law.
The Illinois Department of Financial and Professional Regulation (IDFPR) will work with prescribers to ensure education and compliance with the new mandate. Prescribers not in compliance may be subject to disciplinary action by IDFPR.
For more information and to enroll as a prescriber in the Prescription Monitoring Program (PMP), please visit the IDHS website https://www.ilpmp.org/